Keith Tolley

2.1k total citations
96 papers, 1.6k citations indexed

About

Keith Tolley is a scholar working on Economics and Econometrics, General Health Professions and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Keith Tolley has authored 96 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Economics and Econometrics, 15 papers in General Health Professions and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Keith Tolley's work include Health Systems, Economic Evaluations, Quality of Life (28 papers), Pharmaceutical Economics and Policy (15 papers) and Healthcare Policy and Management (11 papers). Keith Tolley is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (28 papers), Pharmaceutical Economics and Policy (15 papers) and Healthcare Policy and Management (11 papers). Keith Tolley collaborates with scholars based in United Kingdom, Netherlands and France. Keith Tolley's co-authors include Stefan Vegter, David K. Whynes, Caroline Sabin, Maarten J. Postma, Pam Gillies, Jane Wolstenholme, A Miners, Eduard J. Beck, Darrin Baines and Doug Coyle and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Keith Tolley

94 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Tolley United Kingdom 26 446 312 308 298 276 96 1.6k
Thomas Mittendorf Germany 23 465 1.0× 308 1.0× 160 0.5× 248 0.8× 53 0.2× 105 1.7k
Ewa Orlewska Poland 11 697 1.6× 204 0.7× 87 0.3× 331 1.1× 97 0.4× 51 1.7k
Beth Woods United Kingdom 15 370 0.8× 179 0.6× 83 0.3× 187 0.6× 142 0.5× 59 1.5k
Elizabeth A. Middleton United States 23 355 0.8× 556 1.8× 393 1.3× 594 2.0× 704 2.6× 49 2.7k
Neil Wintfeld United States 22 319 0.7× 470 1.5× 78 0.3× 361 1.2× 123 0.4× 42 2.0k
Jörg Mahlich Germany 21 341 0.8× 229 0.7× 77 0.3× 156 0.5× 113 0.4× 101 1.2k
Fowzia Ibrahim United Kingdom 28 83 0.2× 428 1.4× 385 1.3× 159 0.5× 634 2.3× 97 2.4k
Rajiv Mallick United States 19 177 0.4× 167 0.5× 258 0.8× 52 0.2× 152 0.6× 70 1.3k
Lisa K. Hicks Canada 26 139 0.3× 402 1.3× 427 1.4× 288 1.0× 439 1.6× 112 2.7k
G.J. Bonsel Netherlands 19 143 0.3× 223 0.7× 260 0.8× 200 0.7× 84 0.3× 43 1.5k

Countries citing papers authored by Keith Tolley

Since Specialization
Citations

This map shows the geographic impact of Keith Tolley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Tolley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Tolley more than expected).

Fields of papers citing papers by Keith Tolley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Tolley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Tolley. The network helps show where Keith Tolley may publish in the future.

Co-authorship network of co-authors of Keith Tolley

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Tolley. A scholar is included among the top collaborators of Keith Tolley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Tolley. Keith Tolley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yitong, Keith Tolley, François Clément, & Mondher Toumi. (2025). Machine learning-based models for prediction of innovative medicine reimbursement decisions in Scotland. PubMed. 73(1). 202802–202802.
4.
Proudfoot, Clare, et al.. (2022). Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review. The European Journal of Health Economics. 24(3). 453–467. 6 indexed citations
6.
Mera, António Galán de, Emilio González‐Parra, José Antonio Herrero, et al.. (2015). Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis. Health Economics Review. 5(1). 49–49. 6 indexed citations
7.
Tolley, Keith, Michael Hutchinson, Andrew R. Pachner, et al.. (2014). Systematic Literature Review and Network Meta-Analysis of Pegylated Interferon Beta-1a and Disease Modifying Therapies for Relapsing-Remitting Multiple Sclerosis (P7.234). Neurology. 82(10_supplement). 1 indexed citations
8.
Bassi, Abhinav, Keith Tolley, G. Wiseman, & Stanley Y. Shaw. (2014). PTU-066 A Model To Assess The Cost Of Flare In Ulcerative Colitis (uc) To The Nhs. Gut. 63(Suppl 1). A67.2–A67. 1 indexed citations
9.
Kay, Stephen, Keith Tolley, Danielle Colayco, et al.. (2013). Mapping EQ-5D Utility Scores from the Incontinence Quality of Life Questionnaire among Patients with Neurogenic and Idiopathic Overactive Bladder. Value in Health. 16(2). 394–402. 29 indexed citations
10.
Schlander, Michael, Silvio Garattini, Peter L. Kolominsky‐Rabas, et al.. (2013). Incremental Cost Per Quality-adjusted Life Year Gained? The Need for Alternative Methods to Evaluate Medical Interventions for Ultra-rare Disorders. Value in Health. 16(7). A324–A324. 4 indexed citations
11.
Tramarin, Andrea, Stefano Campostrini, Maarten J. Postma, et al.. (2004). A Multicentre Study of Patient Survival, Disability, Quality of Life and Cost of Care. PharmacoEconomics. 22(1). 43–53. 31 indexed citations
12.
Sabin, Caroline, et al.. (2002). Cost-Utility Analysis of Primary Prophylaxis versus Treatment On-Demand for Individuals with Severe Haemophilia. PharmacoEconomics. 20(11). 759–774. 65 indexed citations
13.
Tolley, Keith, et al.. (1998). Economic Aspects of Non-Hodgkin's Lymphoma. RePEc: Research Papers in Economics. 6 indexed citations
14.
Tramarin, Andrea, Stefano Campostrini, Keith Tolley, & Fausto de Lalla. (1997). The influence of socioeconomic status on health service utilisation by patients with AIDS in North Italy. Social Science & Medicine. 45(6). 859–866. 15 indexed citations
15.
Tolley, Keith, et al.. (1996). Health promotion and health economics.. Health Education Research. 11(3). 1 indexed citations
16.
Fitzsimons, David W., et al.. (1995). The economic and social impact of AIDS in Europe.. Cassell eBooks. 27 indexed citations
17.
Tolley, Keith, et al.. (1995). Communication AIDS for the Speech Impaired:Cost and Quality-of-Life Outcomes of Assessment Programs Provided by Speciaiist Communication Aids Centers in the United Kingdom. International Journal of Technology Assessment in Health Care. 11(2). 196–213. 5 indexed citations
18.
Postma, Maarten J., Reiner Leidl, Angela M. Downs, et al.. (1993). Economic impact of the AIDS epidemic in the European Community. AIDS. 7(4). 541–554. 18 indexed citations
19.
Corden, Anne, et al.. (1992). Meeting needs in an affluent society : a multi-disciplinary perspective. Avebury eBooks. 2 indexed citations
20.
Tolley, Keith & Nancy Rowland. (1991). Identification of alcohol‐related problems in a general hospital setting: a cost‐effectiveness evaluation. British Journal of Addiction. 86(4). 429–438. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026